Outcome of Phlebotomy for Treating Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

22 Nov 2016Veeravich Jaruvongvanich, Tanawan Riangwiwat, Anawin Sanguankeo, and Sikarin Upala

Phlebotomy decreased insulin resistance and liver transaminase levels in patients with nonalcoholic fatty liver disease. In addition, it improved their lipid profile.

Meta Analysis
2 effects
10 months
438 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Blood Donation Selfcare risk & protective factor
Minor Protective Factor Blood Donation
Selfcare

Non Fatty Liver Disease Digestive outcome
Minor decreased risk of Non Fatty Liver Disease
Digestive system

Moderate evidence
-50.0%

Blood Donation Selfcare risk & protective factor
Protective Factor Blood Donation
Selfcare

Insulin Resistance Lymphatic outcome
Decreased risk of Insulin Resistance
Lymphatic system

High evidence
-70.0%